Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Topic Ketorolac to Treat Center Point Thickness Secondary to Panphotocoagulation in Proliferative Diabetic Retinopathy

NCT00907114 is registered in ClinicalTrials.gov with Hospital Juarez de Mexico as lead sponsor.

NCT NCT00907114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00907114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Topic Ketorolac to Treat Center Point Thickness Secondary to Panphotocoagulation in Proliferative Diabetic Retinopathy
Lead sponsor
Hospital Juarez de Mexico
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2015
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, proliferative diabetic retinopathy